SCHEMBL21883698

SCHEMBL21883698

CCCc1c(C)ccc(F)c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 1/20 0.39
LDHA P00338 3/20 0.37
LDHB P07195 3/20 0.37
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
CXCR5 P32302 1/20 0.35
F2RL1 P55085 3/20 0.34
HPGD P15428 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
RECQL P46063 1/20 0.32
HSD17B3 P37058 1/20 0.31
ESR1 P03372 1/20 0.31
ALOX5 P09917 1/20 0.31
ERN1 O75460 1/20 0.31
NPC1 O15118 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13563242 0.85 F2RL1 (0.36) LDHALDHBF2RL1HPGDKDM4E
SCHEMBL19880547 0.83 NOS3 (0.35) NOS2PTGS1PTGS2ALDH1A1CYP3A4
SCHEMBL2047097 0.83 NOS2 (0.44) NOS2LDHALDHBHPGDKDM4E
SCHEMBL135071 0.82 ALDH1A1 (0.40) PTGS1PTGS2KDM4EALDH1A1
SCHEMBL19115415 0.79 F2RL1 (0.42) NOS2CXCR5F2RL1HPGDKDM4E
SCHEMBL5681133 0.79 NOS2 (0.41) NOS2LDHALDHBHPGDESR1
SCHEMBL23387415 0.78 PRKCI (0.46) NOS2LDHALDHBPTGS2HPGD
SCHEMBL23491275 0.78 HPGD (0.44) PTGS1PTGS2HPGDKDM4EALDH1A1
SCHEMBL28700541 0.76 NOS2 (0.39) NOS2LDHALDHBHPGDKDM4E
SCHEMBL20076488 0.75 NOS2 (0.37) NOS2CXCR5F2RL1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10597377-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597377-B2 Somatostatin modulators and uses thereof SSTR5, SSTR2, SSTR4 NOS2 1227/4885LDHA 3305/4885LDHB 2701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.